Positron Emission Tomography (PET) Contrast Agent Kinetics and Safety: [18F]-Fluoromannitol

by palligoelme@gmail.com | Aug 7, 2025 | Clinical Trials

​ Conditions: Healthy Interventions: Drug: [18F]-fluoromannitol Sponsors: St. Jude Children’s Research Hospital Not yet recruiting Conditions: Healthy Interventions: Drug: [18F]-fluoromannitol Sponsors: St. Jude Children’s Research Hospital Not yet...

Robot-assisted Adrenalectomy, Feasibility and Results

by palligoelme@gmail.com | Aug 7, 2025 | Clinical Trials

​ Conditions: Adrenalectomy Sponsors: Central Hospital, Nancy, France Active, not recruiting Conditions: Adrenalectomy Sponsors: Central Hospital, Nancy, France Active, not recruiting 

The Effect of TUBER Recommendations and the DASH Diet on Blood Parameters in Patients With Gestational Diabetes

by palligoelme@gmail.com | Aug 7, 2025 | Clinical Trials

​ Conditions: Gestational Diabetes Mellitus (GDM); Gestational Diabetes Mellitus in Pregnancy, Diet- Controlled Interventions: Other: Türkiye Nutrition Guideline Diet; Other: DASH Diet Sponsors: Kardelen Kandemir Completed Conditions: Gestational Diabetes Mellitus...

Evaluation of the Efficacy of Injectable Platelet-rich Plasma in Tooth Movement Acceleration With Clear Aligner

by palligoelme@gmail.com | Aug 7, 2025 | Clinical Trials

​ Conditions: Clear Aligner Appliance Interventions: Biological: Platelet-rich plasma Sponsors: Al-Azhar University Not yet recruiting Conditions: Clear Aligner Appliance Interventions: Biological: Platelet-rich plasma Sponsors: Al-Azhar University Not yet...

Optimization of Oocyte Warming Protocols

by palligoelme@gmail.com | Aug 6, 2025 | Clinical Trials

​ Conditions: Oocyte Cryopreservation Interventions: Other: Thawing protocol; Other: thawing protocol; Other: thawing protocol Sponsors: IRCCS San Raffaele Active, not recruiting Conditions: Oocyte Cryopreservation Interventions: Other: Thawing protocol; Other:...

A Study of LY4256984 in Participants With Sporadic Amyotrophic Lateral Sclerosis

by palligoelme@gmail.com | Aug 6, 2025 | Clinical Trials

​ Conditions: ALS (Amyotrophic Lateral Sclerosis) Interventions: Drug: LY4256984; Drug: Placebo Sponsors: Eli Lilly and Company Not yet recruiting Conditions: ALS (Amyotrophic Lateral Sclerosis) Interventions: Drug: LY4256984; Drug: Placebo Sponsors: Eli Lilly and...